Skip to content

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02187614
Enrollment
1645
Registered
2014-07-11
Start date
2014-08-31
Completion date
2015-03-31
Last updated
2015-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic, Urinary Calculi

Keywords

Acute Renal colic, Acute Ureteric Colic, Renal or Ureteral Calculi, Urolithiasis, Kidney or Ureteral stones

Brief summary

Abdominal pain is one of the most common presentations to an emergency department (ED). Among patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and to be pain free as early as possible. There are variations in physician preference to choose initial analgesic drug for managing such pain. Commonly used drugs are: * Opioids such as Morphine or Fentanyl * Non steroidal drugs such as Diclofenac, Ketorolac or Brufen * and Paracetamol intravenous injection. A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking. This study is design to obtain data on efficacy of these three drugs within 30 minutes in a non inferiority trail.

Detailed description

This will be a double blind RCT, where participants will be enrolled consecutively after meeting eligibility criteria and obtaining a written informed consent. They will be assign to one of the three study arms by computer generated randomization process. The study packets will be prepared by a dedicated nurse or pharmacist who will not a part of investigating team. Each Patients will receive one analgesic drug (active drug) and two placebos. Drugs will be given as one intramuscular injection and two intravenous solutions. Pain score will be recorded using NRS at 0, 30, 60, and 90 minutes. Data will be collected on standard Data collection form. Each participant will receive analgesia from study packet which contains, one active drug and two placebos to be administer as one intramuscular and two intravenous solutions. At any given time every patient will receive one analgesia from either Diclofenac, Paracetamol or Morphine. If patient pain does not respond to initial treatments, at 30 minutes a rescue analgesia in form of morphine will be administered till patient is pain free or NRS\<=2 or adverse event to morphine. Based on the results of previous studies (1-3), proportion of patients achieving more than 50% pain reduction, is between 65-75% for diclofenac, morphine and paracetamol when compared with other drugs. In each group, 437 patients are required to detect a difference of 10% in primary outcome, in a superiority trial with power (1-beta) of 90% and significance level (alpha) of 5% in this study. Considering 15% extra, total sample size required in this superiority trial will be 1507 patients in total. Data will be collected on a standard data recording form and it will be converted to electronic excel sheet hiding patient identifiable details. Continuous variables will be presented as mean with standard deviation (SD). Categorical variables will be calculated as proportions and presented with 95% Confidence interval (CI). Statistical analyses will be undertaken using Stata 12.0 (College Station, Texas).

Interventions

DRUGDiclofenac
DRUGMorphine
DRUGParacetamol
DRUGPlacebos

Sponsors

Hamad Medical Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age \>=18 years and \< 65 years * Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas. * Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain) * Diagnosis confirmed by non contrast CT KUB within the ED visit.

Exclusion criteria

* Traumatic flank pain * Pregnancy * Known renal failure or impairment * Known allergy to morphine, diclofenac or paracetamol * Bronchial asthma * Previously enrolled in the study. * Use of any analgesia in last 6 hour.

Design outcomes

Primary

MeasureTime frame
The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.at 30 minutes after analgesia

Secondary

MeasureTime frame
reduction in mean NRSat 30, 60 and 90 minutes after analgesia

Other

MeasureTime frame
adverse event rateWithin 14 days of ED visit
total analgesia requirement to get pain score (NRS) less than or equal to 2.by 90 minutes

Countries

Qatar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026